All the blood cells in the human body are produced in the bone marrow and originate from what are known as haematopoietic stem cells. These cells, which are capable of continuously dividing and developing and can, amongst other sources, be isolated from umbilical cord blood, are also used in life-saving transplant treatments. Due to their limited availability, attempts have been made to produce these cells from even earlier cell lines (pluripotent stem cells). However, these efforts failed because simply too little is known about blood progenitor cells. An international team of researchers has now, however, succeeded in drawing up a detailed roadmap describing every step in the development of blood stem cells in the human embryo. This roadmap now helps to better understand the fundamental differences between all cell types and also provides guidance on which cells might be suitable for specific medical interventions. According to the researchers, the developmental journey of immature blood stem cells generally begins in the blood vessel wall. Much like an apprentice, the blood stem cell then continues its development in a wide variety of locations. It travels from the aorta to the bone marrow. In the liver, it acquires its unique ability to divide. Knowledge of the exact journey taken by blood stem cells could now serve as a ‘recipe’ for producing transplantable blood stem cells in the laboratory. The mapping also helps to better understand certain clinical pictures. For example, why some types of blood cancer that develop in the womb are more aggressive than those that occur after birth. Reference: University of California, UCL, University of Tübingen, MCRI Parkville, NMI Reutlingen Mapping human haematopoietic stem cells from haemogenic endothelium to birth, Nature 2022; https://www.nature.com/articles/s41586-022-04571-x
How do haematopoietic stem cells develop?